Cart
Free US shipping over $10
Proud to be B-Corp

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2 Steef van de Velde

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2 By Steef van de Velde

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2 by Steef van de Velde


$286.49
Condition - New
Only 2 left

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2 Summary

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2 by Steef van de Velde

The 7th International Symposium on Platinum and other metal coordination compounds in Cancer Chemotherapy, ISPCC '95, organized by the European Cancer Centre, was held in Amsterdam, the Netherlands, March 1-4, 1995. As with previous ISPCC meetings, the goal of ISPCC '95 was to bring together c1inicians, clinical investigators, scientists, and laboratory workers from many disciplines to promote further collaboration and cooperation in the development of new platinum and other metal coordination compounds as weil as in new ways to use 'c1assical' drugs as cisplatin and carboplatin in the treatment of cancer. Important aspects addressed by experts in the field inc1uded the synthesis and activity of new platinum compounds, the biochemistry and molecular pharrnacology as weil as the c1inical pharrnacology of this c1ass of antineoplastic agents, an overview of current c1inical studies, one special minisymposium on the mechanisms of cell kill of platinum, and one on resistance against platinum compounds. Finally, the current status of development of nonplatinum metal complexes was discussed. This volume contains the contributions of the various speakers at ISPCC '95 and provides an up-to-date and comprehensive overview of this important c1ass of anticancer agents, ranging from synthesis and molecular pharrnacology on one hand to c1inical pharrnacology and cIinical investigations on the other hand. The Organizing Corrunittee and Editors wish to express their gratitude to the contributors to this volume, to the various organizations and pharrnaceutical companies for their generous sponsoring of ISPCC '95, and to the Plenum Publishing Company for their help in producing this volume.

Table of Contents

Synthesis and Activity of Platinum Compounds: NMR Spectroscopy of Platinum Drugs: From DNA to Body Fluids (K.J. Barnham et al.). Transdiamminedichloroplatinum (II) Is Not an Antitumor Drug: Why? (R. Dalbies et al.). Iminoethers as Carrier Ligands: A Novel Transplatinum Complex Possessing in Vitro and in Vivo Antitumor Activity (M. Coluccia et al.). Molecular Dynamics Simulations on Cisplatin Adducts with Dinucleotides (J. Kozelka). Orally Active DACHPt (IV) Compounds (Y. Kidani et al.). Clinical Pharmacology: Pharmacokinetic-Pharmacodynamic Relationships (P. Canal, E. Chatelut). Clinical Pharmacology of Carboplatin Administered in Alternating Sequence with Paclitaxel in Patients with Nonsmall Cell Lung Cancer: A European Cancer Centre (ECC) Study (L.J.C. van Warmerdam et al.). The Clinical Development of the Oral Platinum Anticancer Agent JM216 (I. Judson et al.). Biochemistry and Molecular Pharmacology: Membrane Transportof Platinum Compounds (G. Los et al.). Detection of Adducts Formed upon Treatment of DNA with Cisplatin and Carboplatin (A.M.J. FichtingerSchepman et al.). Detection of Platinum Lesions at the Nucleotide Level in Cells Using Single Strand Ligation PCR (J.A. Hartley et al.). A Review of the Modulation ofCisplatin Toxicities by Chemoprotectants (R.T. Dorr). CombinationTherapy with Cisplatinum and EGF Receptor Blockade (J. Mendelsohnet al.). Clinical Studies: Oxaliplatin: Update on an Activeand Safe Dach Platinum Complex (P. Soulie et al.). Combination of Different Platinum Compounds: Issues, Strategies and Experience (F.M. Muggia). Phase I and II Studies with Lobaplatin (H. Fiebig). Phase I Trials of Ormaplatin (NSC 363812)(M.C. Christian). 254S, NK121 and TRK710 (M. Ogawa). Clinical Trials of Oxaliplatin and DWA2114R (T. Taguchi). Incorporating Assessments of Sequencedependence in Developmental Studies of CombinationChemotherapy Regimens Containing New Agents and Platinum Compounds (E.K. Rowinsky). Review of Carboplatinbased Highdose Chemotherapy Combinations in the Autotransplant Setting(S. Rodenhuis et al.). Treatment Intensification in Germcell Tumors (J.P. Droz et al.). Nonplatinum Metal Complexes: Overview of Tumorinhibiting Nonplatinum Complexes (B.K. Keppler, E.A. Vogel). Phenotypic Aspects of Platinum Resistance (T. Fojo et al.). How Does Platinum Kill the Cell? The Cisplatininduced Cellular Injury Response (S.B. Howell et al.). Controversy Session: Cisplatin vs. Carboplatin? Carboplatinvs. Cisplatin in the Chemotherapy of Solid Tumors: Procarboplatin (D.S. Alberts). Cisplatin and Carboplatin in Testis and Ovarian Cancer: Procisplatin (S.D. Williams). Resistance: Hypersensitivity to Cisplatin in Mouse LeukemiaL1210/0 Cells: An XPG DNA Repair Defect (R. Wood et al.). 4 additional articles. Index.

Additional information

NPB9780306452871
9780306452871
0306452871
Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2 by Steef van de Velde
New
Hardback
Springer Science+Business Media
1996-04-30
358
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Customer Reviews - Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2